Skip to content

Understanding the biological responses to sun exposure in healthy adults

Understanding the biological responses and cellular damage after sun exposure in healthy adults

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000212156
Enrollment
5
Registered
2019-02-13
Start date
2019-02-14
Completion date
2019-03-12
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is aiming to examine the minimum dose of solar exposure required to cause cellular damage and induction of repair pathways. Who is it for? You may be eligible for this study if you are aged 18 years of age or older with skin type 1-3 fair skin. Study details Participants will receive graded sub-erythemal UV doses on their back equal to sunlight in Brisbane during summer at 7 am for 15, 30 and 40 minutes and skin biopsies will be collected 24 hours post UV exposure to analyse the level of cellular damage. A control site will also be biopsied to examine non-exposed UV skin. It is hoped this research will help to assess the current UV exposure guidelines and whether the suggested dose limit is safe or not.

Interventions

Overview: This non-randomised, feasibility study aims to examine the minimum dose of solar exposure required to cause cellular damage and induction of repair pathways. Five adult volunteers aged over 18 years will receive graded sub-erythemal UV doses on their lower back under UV Index 3 (intervention) and skin biopsies will be collected 24 hours post UV exposure to analyse the level of cellular damage. Each UV dosage site is 0.9cm2. A control site will also be biopsied to examine non-exposed UV

Overview: This non-randomised, feasibility study aims to examine the minimum dose of solar exposure required to cause cellular damage and induction of repair pathways. Five adult volunteers aged over 18 years will receive graded sub-erythemal UV doses on their lower back under UV Index 3 (intervention) and skin biopsies will be collected 24 hours post UV exposure to analyse the level of cellular damage. Each UV dosage site is 0.9cm2. A control site will also be biopsied to examine non-exposed UV skin (total 5 biopsies across the study). Participant involvement would include two visits to QUT, Kelvin Grove: Visit 1: • Filling in a survey form asking about your type of skin, your medical history and sun exposure behaviour. • Collection of a saliva sample • One 1mm punch biopsy of a non-UVR exposed site on the lower back by a registered medical practitioner. • One 1mm punch biopsy immediately following UV exposure on your lower back by a registered medical practitioner. • Exposing a row of five square areas of skin on the back (each with an area of 0.9cm2) to a low dose of ultraviolet light (similar to natural sunlight). The exposure will be similar to approximately 15, 30, 40 minutes in the sun before 7am in Brisbane during summer just enough to cause faint redness- to determine how long your skin takes to redden. This is called your Minimal Erythemal Dose (MED). This exposure is less than 1 MED. This is a 1.5 hour visit. Visit 2: • On a subsequent visit the next day participants will have 3 skin biopsies on the lower back that was exposed to UV the previous day by a registered medical practitioner. Each biopsy will be only 1mm diameter and will be taken under local anaesthetic. This is a 1 hour visit. Participants will be provided with an aftercare leaflet, and advised to contact the study team should they have any concerns after the procedures. Participants are supervised by researchers during the visits and sent reminder emails/or texts by the research team to remind them of their appointments.

Sponsors

Queensland University of Technology
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Other
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

healthy adults 18 years of age or older, skin type 1-3 fair skin

Exclusion criteria

Individuals are excluded from participating if they have a history of allergy or adverse reactions to local anaesthetics or any related drug. Participants must not be currently taking medications that induce photosensitivity (you are sensitive to light) or known or suspected to reduce, inflammation immunity or healing (e.g. corticosteroids). Participants must not be on blood thinning medication. Participants are also excluded if they are pregnant, have a history of skin cancer, keloid scarring, heart disease, liver disease, kidney disease, diabetes of any type, or any significant gastrointestinal disorder.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026